Milpharm

Milpharm is a prominent pharmaceutical company based in the United Kingdom and operates as a wholly-owned subsidiary of the global pharmaceutical giant Aurobindo Pharma. The company is primarily focused on the development, marketing, and distribution of a vast portfolio of generic medicines, catering to the National Health Service (NHS) and the wider UK healthcare market. Milpharm's product range spans numerous therapeutic categories, including cardiovascular health, central nervous system disorders, and gastrointestinal conditions. By leveraging the extensive manufacturing capabilities of its parent company, Milpharm provides cost-effective and high-quality therapeutic alternatives. The company plays a vital role in Aurobindo's European strategy, ensuring a consistent supply of essential medicines to patients.